INMB Bathi mangsa ngarep INmune Bio Inc
International cooperation and overseas patent protection are critically important for INmune Bio, Inc. (INMB) amid current geopolitical conditions. Stable demand for biotechnology makes the company a defensive asset independent of macroeconomics. Analyst earnings expectations demonstrate the potential for innovation in Alzheimer's and cancer therapies, while the level captures the current state of the business's projected cash flows.
Rincian analitis perusahaan INmune Bio, Inc.
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas INmune Bio, Inc.|INMB - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas INmune Bio Corporation|INMB - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku INmune Bio Corporation|INMB - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan INmune Bio|Rasio cepet inmunebio.com
- informasi bathi lan kelipatan valuasi:
INMB - Asil keuangan resik|Bathi sing dikarepake INmune Bio, Inc.|INMB - Pangali rega marang bathi|Rega marang bathi mangsa ngarep INmune Bio Corporation|INMB - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan INmune Bio, Inc.|INMB - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan INmune Bio|INMB - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan inmunebio.com|INMB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep INmune Bio, Inc.
- rincian pendapatan lan dodolan:
Analisis dhasar perusahaan:INMB, INmune Bio Corp
The diversification of INmune Bio, Inc. (INMB) developments in immunology directly impacts the real-time valuation of future earnings. This indicator measures the business's expected ability to generate net income over the medium term. The calculation is based on cash flow projections from successful clinical trials. The positive trend confirms the company's transition to the product commercialization stage. Investors should avoid impulsive buying at the first signs of a reversal.
Perusahaan pesaing
ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Prakiraan bathi resik ZBIO (Zenas Biopharma, Inc.)|Bathi mangsa ngarep IMNM (Immunome Bio)|Prakiraan bathi perusahaan Gossamer Bio, Inc.|Proyeksi bathi mangsa ngarep KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Bathi resik sing dikarepake|PVLA - Bathi sing dikarepake|SVRA - Proyeksi bathi mangsa ngarep|Rigel Pharmaceuticals Inc (RIGL) - Bathi sing dikarepake|ANAB - Prakiraan bathi perusahaan|Bathi mangsa ngarep ATXS|ENGN: Penghasilan resik sing dikarepake|Bathi sing dikarepake RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ACRS (Aclaris Therapeutics)|Penghasilan resik sing dikarepake KYTX|Tiziana Life Sciences - Proyeksi bathi mangsa ngarep|CABA: Bathi sing dikarepake|VTYX: Proyeksi bathi mangsa ngarep|THTX (Theratechnologies, Inc) - Bathi sing dikarepake|AVTX (Avalo Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Eledon Pharmaceuticals|Bathi sing dikarepake Agenus Inc. (AGEN)|Bathi mangsa ngarep Climb Bio Inc. CLYM|Proyeksi bathi mangsa ngarep ZURA (Zura Bio Ltd)|ATYR - Bathi mangsa ngarep|ADAG - Bathi sing dikarepake|IMA - Proyeksi bathi mangsa ngarep|STTK: Proyeksi bathi mangsa ngarep|Equillium Bio (EQ) - Proyeksi bathi mangsa ngarep|CNTB (connectbiopharm.com) - Proyeksi bathi mangsa ngarep|IMUX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ATRA|Proyeksi bathi mangsa ngarep InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Bathi forward|Proyeksi bathi mangsa ngarep adicetbio.com ACET|Celularity - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep
